SUMMARY
The research of Collin M. Costello, M.D., advances Mayo Clinic's presence as a tertiary referral center for melanoma in the Southwest. His research studies artificial intelligence (AI)-driven diagnostic imaging technologies for melanomas.
Dr. Costello engages in improving melanoma research through teledermatology/imaging technology, melanoma prevention in Latino populations, the pathogenesis of acral melanoma, dermoscopy of acral nevi and melanoma, and the molecular staging of high-risk cutaneous squamous cell carcinoma. Dr. Costello aims to better understand skin cancer's complexities and nuances.
Focus areas
- Dr. Costello studies AI-driven diagnostic imaging technologies for melanoma and cutaneous oncology.
- He highlights melanoma disparities through teledermatology/imaging technology.
- Dr. Costello incorporates genomic and whole slide AI analysis imaging to improve the understanding of melanoma.
Significance to patient care
Dr. Costello focuses on technology, such as dermoscopy confocal microscopy, whole slide imaging, total-body photography, genomics and artificial intelligence, to transform melanoma and cutaneous oncology healthcare delivery. Dr. Costello closes the inequity gaps in melanoma and cutaneous oncology care. His lab decentralizes research trials within diagnostic imaging to improve care and minority access to this research.